Order Number |
636738393092 |
Type of Project |
ESSAY |
Writer Level |
PHD VERIFIED |
Format |
APA |
Academic Sources |
10 |
Page Count |
3-12 PAGES |
Assignment Overview
As a consultant, you need to develop an in-depth analysis and evaluation of the selected agency’s planning, organizational design, decision-making process, and implementation, and then provide recommendations for improvement.
Therefore, you will conduct interviews with agency representatives and research related academic sources, the agency’s website, or any government website. The analysis will be read by the VP of accounts and client support, as well as by the leaders of the agency for whom you are working.
Assignment Instructions
Write a 5–7-page paper in which you:
Describe the history of the selected agency and department by explaining its reasons (goals and objectives) for being established. Title this section History of [Selected Agency].
Analyze the organizational design of the selected agency and specific department by describing the design and organizational chart. Assess its effectiveness in making major policy decisions and providing services to its primary recipients. Title this section Organizational Design.
Include a figure of the current organizational design within the text of the paper.
Recommend a redesign of the agency’s structure to better serve the needs of the department’s businesses without jeopardizing the goals and objectives of the agency. Explain your reasoning for changing the design, and explain the change’s impact on the agency’s effectiveness in delivering quality services. Title this section Assessment of Organizational Design.
Include a figure of the new organizational design within the text of the paper.
Analyze 2–3 major milestones, factors (internal or external), or actors affecting the agency’s success and their influence on the effectiveness of the agency’s planning, organizational design, decision making, and implementation.
Also, analyze 2–3 possible causes (internal or external) that appear to have the effect of impeding the organization’s implementation of its policy and meeting its goals and objectives. Title this section Evaluation of Planning and Implementation.
Recommend 2–3 strategies (from the previous criterion) that the agency could implement to improve its effectiveness in the areas of planning, decision making, organization, and implementation, by explaining each recommendation and providing reasons each recommendation would bring about improvement. Title this section Recommendations for Planning and Implementation.
Include a cause-and-effect diagram in the text of the paper.
Provide the completed PAD599 Interview Template for 1–2 interviews, putting this information in the Appendix under Interviews.
Go to Basic Search: Strayer University Online Library to locate and list 4–5 relevant and credible outside resources that support the content of this assignment. Include no more than one non-government website.
Note: Follow the Guidelines for Interview Assignments at Strayer University provided in the Assignment Preparation in Week 1.
Your assignment must follow these formatting requirements:
Be typed and double spaced, using Times New Roman font (size 12), with one-inch margins on all sides; citations and references must follow APA format. Check with your professor for any additional instructions.
Include a cover page containing the title of the assignment, your name, the professor’s name, the course title, and the date. The sections must have appropriate titles. The cover page, reference page, and the appendix pages are not included in the required assignment page length. The assignment must be submitted as a Microsoft Word document.
The specific course learning outcome associated with this assignment is:
Conduct an in-depth analysis and evaluation of an agency’s planning, organizational design, decision-making process, and implementation, and provide recommendations for improvement.
Agency Selection
PAD 599
Food and Drug Administration (FDA)
The rationale for Agency Selected
Introduction
The Federal Drug Administration is one of the federal agencies in the United States Department of Health and Human Services. The agency was founded in 1906 under the administration of President Theodore Roosevelt. The agency has its headquarters in White Oak Campus, New Hampshire Avenue. Silver Spring, Maryland.
The primary responsibility of the agency is to promote the safety of “food, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.”
Mission
“The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation” (FDA, 2020).
Goals and objectives
Functions of the Agency
The Federal Drug Administration is one of the most important agencies since it is at the heart of the country’s health systems. Firstly, this agency has the function of making sure that the drugs that are being manufactured by the country’s medicines are safe.
Since most drugs are developed by private enterprises, it is necessary for the government to make sure the drugs that they manufacture will not hurt the public. Another important function of this organization is to regulate tobacco use. This organization is responsible for making sure that it regulates the production and marketing of tobacco in a manner that protects the public (Carpenter, 2014).
It is also the responsibility of the organization to make sure that it encourages innovation in the field of healthcare. The agency also plays an important role in making sure that there is food security in the United States by making sure that there is a steady and consistent supply.
Current Events
One of the current events concerning the organization is the coronavirus pandemic. The pandemic is s global crisis that has brought the world to a stop. In the face of these challenges, many organizations are coming up with medications and vaccines to address the virus. It is the responsibility of the organization to make sure that these medications and vaccines that are being developed meet the desired quality standards (Prompetchara et al., 2020).
The second event that concerns the agency is the surge in the number of counterfeit drugs in the market. There are reports that there are many medications that have sneaked into the market without going through the regulatory tests (Blackstone et al., 2014). There is a need to find the mechanisms through which the organization may prevent the entry of untested drugs into the market.
Rationale
The primary reason for settling on this organization is related to the purpose of the organization in the management of the present pandemic. The Federal Drug Administration is responsible for making sure that there are drugs that may be used to safely address the pandemic.
At this time, the agency is required to put its best foot forward and make sure that there are adequate measures to test the safety of emerging COVID-19 drugs. The second reason for the selection of this agency is its role in protecting Americans from the drugs that are being brought into the market illegally.
References
Blackstone, E. A., Fuhr Jr, J. P., & Pociask, S. (2014). The health and economic effects of counterfeit drugs. American health & drug benefits, 7(4), 216.
Carpenter, D. (2014). Reputation and power: organizational image and pharmaceutical regulation at the FDA (Vol. 137). Princeton University Press.
Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol, 38(1), 1-9.
U.S Food and Drug Administration. (2020). What We Do. Retrieved from https://www.fda.gov/about-fda/what-we-do